chr18-9117869-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000318388.11(NDUFV2):āc.86T>Cā(p.Val29Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.811 in 1,595,082 control chromosomes in the GnomAD database, including 525,894 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
ENST00000318388.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFV2 | NM_021074.5 | c.86T>C | p.Val29Ala | missense_variant | 2/8 | ENST00000318388.11 | NP_066552.2 | |
NDUFV2 | XM_017025782.2 | c.-2T>C | 5_prime_UTR_variant | 2/8 | XP_016881271.1 | |||
NDUFV2 | XR_243808.4 | n.131T>C | non_coding_transcript_exon_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFV2 | ENST00000318388.11 | c.86T>C | p.Val29Ala | missense_variant | 2/8 | 1 | NM_021074.5 | ENSP00000327268 | P1 |
Frequencies
GnomAD3 genomes AF: 0.790 AC: 120110AN: 152030Hom.: 47658 Cov.: 32
GnomAD3 exomes AF: 0.798 AC: 200495AN: 251114Hom.: 80523 AF XY: 0.805 AC XY: 109345AN XY: 135798
GnomAD4 exome AF: 0.813 AC: 1172718AN: 1442934Hom.: 478193 Cov.: 30 AF XY: 0.815 AC XY: 585798AN XY: 719068
GnomAD4 genome AF: 0.790 AC: 120207AN: 152148Hom.: 47701 Cov.: 32 AF XY: 0.787 AC XY: 58539AN XY: 74374
ClinVar
Submissions by phenotype
Mitochondrial complex 1 deficiency, nuclear type 7 Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 11, 2021 | - - |
not provided Benign:3
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 19, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 03, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Parkinson disease, mitochondrial Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | OMIM | Apr 01, 1998 | - - |
Mitochondrial complex I deficiency, nuclear type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at